home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

3rd Annual Drug Discovery USA Congress 2016

 
  June 23, 2016  
     
 
Oxford Global, Hilton San Diego Mission Valley, 901 Camino del Rio, South San Diego
3rd and 4th October 2016


Oxford Global Conferences are proud to present the 3rd Annual Drug Discovery USA Congress, taking place on 3-4 October 2016 in San Diego, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

40 presentations and case studies focused on the key issues in drug discovery and medicinal chemistry

4 Interactive Streams:

- Target Based Discovery
- Screening & Assays: Enabling Technologies
- Discovery Chemistry & Drug Design
- Supporting Innovation: Translational Approaches & Informatics Tools

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

The drug discovery landscape is changing rapidly. With the cost of bringing a drug to market rising, researchers are seeking innovative ways to increase the efficiency of their R&D pipelines. On the first day of our Drug Discovery USA Congress our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. Our renowned speakers will explore novel peptide drug discovery, strategies for target selection and incorporating genomic technologies into discovery research. Day one also features an exciting stream covering the latest screening and assay technologies, such as novel stem cell assays, exciting new phenotypic screening strategies and how to use stem and primary cells for physiologically relevant disease models.

The pharma industry is seeing an increased focus on strengthening data and knowledge management in R&D pipelines to make the most of discovery data. Researchers are seeking new techniques to manage complex early stage discovery portfolios and for library optimisation. On day two our Congress features an exciting stream dedicated to supporting innovation with informatics tools in which we will explore new data analysis and integration platforms, as well as ideas for efficient data exchange and pre-competitive collaboration. Day two will also host discussions about the latest research in the discovery chemistry field, with exciting case studies covering computational tools for gene editing and drug design as well as fragment based drug discovery case studies.
 
 
Organized by: Oxford Global
Invited Speakers:
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

- Vincent Stoll, Associate Director, Structural Biology, AbbVie

- Leticia Toledo-Sherman, Director of Computer Aided Drug Design and Medicinal Chemist, CHDI Foundation

- Neel Anand, Director Medicinal Chemistry, Nektar Therapeutics

- Hicham Alaoui, Director, Biochemical and Cellular Pharmacology, Genentech

- Thomas Hoegberg, Senior Scientific Adviser, LEO Pharma

- Jing Li, Director, Genomics and Phenotypic Screening, Merck

- Lisa Mendoza, Associate Director, Global External Innovation & Alliances, Bayer

- Lidio Meireles, Research Scientist II, Modeling & Informatics, Vertex Pharmaceuticals

- Natia Tsomaia, Associate Director, Ipsen
 
Deadline for Abstracts: N/A
 
Registration:

All general enquiries
Tel: +44 (0)1865 248455
Fax: +44 (0)1865 250985

For speaker opportunities contact j.clark@oxfordglobal.co.uk

For sponsorship opportunities contact sponsorship@oxfordglobal.co.uk

For press & marketing enquiries contact g.alonso@oxfordglobal.co.uk



E-mail: g.alonso@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.